← Leaderboards
Gayani Tillekeratne
Duke University
$4,181,191
Attributed
$4,181,191
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $918K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,181,191 · 4
By mechanism
R01$2,587,582 · 1
K23$904,948 · 1
R21$688,661 · 2
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- David C. Steffens$35,311,674
- Jed E Rose$13,228,741
- Vance G Fowler$95,483,666
- Laura P Svetkey$25,471,440
- Anthony Sung$6,109,667
Others in their field
Other Emerging Leaders on “Country”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Bambra Strokes · Ppd Development Lp$65,000,267
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
Research focus
CountryEnrollmentInfectionDiagnosticPathogenViralSri LankaIncomeEtiologyBacterial InfectionsBiological MarkersProcalcitoninLaboratoriesCohortInfrastructureInfluenzaClinical Trials DesignPhysiciansDiagnostic TestsAntibioticsTeaching HospitalsResponseHospitalsBiobank
Grant awards (13)
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting$541,968
R01 · FY2025 · AI · contact PI
Combined pathogen and host-based diagnostic to identify etiology of lower respiratory tract infection$244,044
R21 · FY2025 · AI · contact PI
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting$107,296
R01 · FY2025 · AI · contact PI
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting$631,554
R01 · FY2024 · AI · contact PI
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting$672,361
R01 · FY2023 · AI · contact PI
Host response-based diagnostics for identifying bacterial versus viral causes of lower respiratory infection in resource-limited settings$161,000
R21 · FY2023 · AI · contact PI
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting$634,403
R01 · FY2022 · AI · contact PI
Host response-based diagnostics for identifying bacterial versus viral causes of lower respiratory infection in resource-limited settings$283,617
R21 · FY2022 · AI · contact PI
Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings$166,821
K23 · FY2021 · AI · contact PI
Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings$180,777
K23 · FY2020 · AI · contact PI
Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings$182,963
K23 · FY2019 · AI · contact PI
Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings$185,820
K23 · FY2018 · AI · contact PI
Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings$188,567
K23 · FY2017 · AI · contact PI